{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T16:48:09Z","timestamp":1770569289931,"version":"3.49.0"},"reference-count":42,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.3892\/ol.2017.6473","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T10:40:01Z","timestamp":1498214401000},"page":"3019-3027","source":"Crossref","is-referenced-by-count":25,"title":["A cytokine signal inhibitor for rheumatoid arthritis enhances cancer metastasis via depletion of NK cells in an experimental lung metastasis mouse model of colon cancer"],"prefix":"10.3892","volume":"14","author":[{"given":"Hideki","family":"Shimaoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Maki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahide","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,6,23]]},"reference":[{"key":"key20180108114349_b1-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/0952-7915(95)80080-8","article-title":"The role of natural killer cells in immune surveillance of cancer","volume":"7","author":"Whiteside","year":"1995","journal-title":"Curr Opin Immunol"},{"key":"key20180108114349_b2-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.4049\/jimmunol.127.5.1754","article-title":"Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo","volume":"127","author":"Hanna","year":"1981","journal-title":"J Immunol"},{"key":"key20180108114349_b3-ol-0-0-6473","first-page":"4020","article-title":"Enhancement of metastatic potential by gamma-interferon","volume":"51","author":"Kelly","year":"1991","journal-title":"Cancer Res"},{"key":"key20180108114349_b4-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/ijc.25281","article-title":"NK depletion results in increased CCL22 secretion and Treg levels in Lewis lung carcinoma via the accumulation of CCL22-secreting CD11b+CD11c+ cells","volume":"127","author":"Mailloux","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180108114349_b5-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1097-0215(19960717)67:2<211::AID-IJC11>3.0.CO;2-E","article-title":"Novel metastasis model of human lung cancer in SCID mice depleted of NK cells","volume":"67","author":"Yano","year":"1996","journal-title":"Int J Cancer"},{"key":"key20180108114349_b6-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P","article-title":"The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma","volume":"79","author":"Coca","year":"1997","journal-title":"Cancer"},{"key":"key20180108114349_b7-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V","article-title":"Prognostic value of intratumoral natural killer cells in gastric carcinoma","volume":"88","author":"Ishigami","year":"2000","journal-title":"Cancer"},{"key":"key20180108114349_b8-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1158\/0008-5472.CAN-10-1322","article-title":"CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes","volume":"70","author":"Bos","year":"2010","journal-title":"Cancer Res."},{"key":"key20180108114349_b9-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/eji.1830171231","article-title":"CD4+ helper T cells are required for resistance to a highly metastatic murine tumor","volume":"17","author":"Schild","year":"1987","journal-title":"Eur J Immunol"},{"key":"key20180108114349_b10-ol-0-0-6473","first-page":"309","article-title":"Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer","volume":"10","author":"Funada","year":"2003","journal-title":"Oncol Rep"},{"key":"key20180108114349_b11-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/ar2556","article-title":"Garden of therapeutic delights: New targets in rheumatic diseases","volume":"11","author":"Waldburger","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"key20180108114349_b12-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1124\/pr.114.009639","article-title":"Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases","volume":"67","author":"Siebert","year":"2015","journal-title":"Pharmacol Rev"},{"key":"key20180108114349_b13-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/art.27268","article-title":"Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: A two-year, double-blind, randomized study","volume":"62","author":"Emery","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key20180108114349_b14-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3899\/jrheum.120687","article-title":"Longterm safety and efficacy of tocilizumab in patients with rheumatoid arthritis: A cumulative analysis of up to 4.6 years of exposure","volume":"40","author":"Genovese","year":"2013","journal-title":"J Rheumatol"},{"key":"key20180108114349_b15-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"504","DOI":"10.5312\/wjo.v5.i4.504","article-title":"Efficacy and safety of tofacitinib for treatment of rheumatoid arthritis","volume":"5","author":"Lundquist","year":"2014","journal-title":"World J Orthop"},{"key":"key20180108114349_b16-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJMoa1112072","article-title":"Tofacitinib or adalimumab versus placebo in rheumatoid arthritis","volume":"367","author":"van Vollenhoven","year":"2012","journal-title":"N Engl J Med"},{"key":"key20180108114349_b17-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1002\/art.24126","article-title":"Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses","volume":"58","author":"Fujimoto","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key20180108114349_b18-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/ar2365","article-title":"Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis","volume":"10","author":"Milici","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"key20180108114349_b19-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/1529-0131(199812)41:12<2117::AID-ART6>3.0.CO;2-P","article-title":"Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis","volume":"41","author":"Takagi","year":"1998","journal-title":"Arthritis Rheum"},{"key":"key20180108114349_b20-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0165-2478(02)00202-X","article-title":"Characterization of anti-mouse interleukin-6 receptor antibody","volume":"84","author":"Okazaki","year":"2002","journal-title":"Immunol Lett"},{"key":"key20180108114349_b21-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1189\/jlb.0504282","article-title":"The JAK3 inhibitor CP-690550 selectively reduces NK and CD8+ cell numbers in cynomolgus monkey blood following chronic oral dosing","volume":"76","author":"Conklyn","year":"2004","journal-title":"J Leukoc Biol"},{"key":"key20180108114349_b22-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1600-6143.2003.00281.x","article-title":"The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models","volume":"4","author":"Kudlacz","year":"2004","journal-title":"Am J Transplant"},{"key":"key20180108114349_b23-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/rheumatology\/ket466","article-title":"Effects of tofacitinib on lymphocytes in rheumatoid arthritis: Relation to efficacy and infectious adverse events","volume":"53","author":"Sonomoto","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"key20180108114349_b24-ol-0-0-6473","volume-title":"Advisory Committee meeting. Tofacitinib for treatment of rheumatoid arthritis (NDA 203214)","author":"U.S. Food and Drug Administration","year":"2012"},{"key":"key20180108114349_b25-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3892\/or.2014.3634","article-title":"Combination therapy with \u03b1-galactosylceramide and a Toll-like receptor agonist exerts an augmented suppressive effect on lung tumor metastasis in a mouse model","volume":"33","author":"Ando","year":"2015","journal-title":"Oncol Rep"},{"key":"key20180108114349_b26-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.2010.30.5425","article-title":"Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction","volume":"29","author":"Mlecnik","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20180108114349_b27-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","article-title":"IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation","volume":"9","author":"Lodolce","year":"1998","journal-title":"Immunity"},{"key":"key20180108114349_b28-ol-0-0-6473","doi-asserted-by":"crossref","unstructured":"WaldmannTAThe biology of IL-15: Implications for cancer therapy and the treatment of autoimmune disordersJ Investig Dermatol Symp Proc16S28S30201310.1038\/jidsymp.2013.824326545","DOI":"10.1038\/jidsymp.2013.8"},{"key":"key20180108114349_b29-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1182\/blood-2008-10-187179","article-title":"Maturation of mouse NK cells is a 4-stage developmental program","volume":"113","author":"Chiossone","year":"2009","journal-title":"Blood"},{"key":"key20180108114349_b30-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2567.2011.03446.x","article-title":"CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells","volume":"133","author":"Fu","year":"2011","journal-title":"Immunology"},{"key":"key20180108114349_b31-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"712","DOI":"10.4049\/jimmunol.1201837","article-title":"NK cell maturation and function in C57BL\/6 mice are altered by caloric restriction","volume":"190","author":"Clinthorne","year":"2013","journal-title":"J Immunol"},{"key":"key20180108114349_b32-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.4049\/jimmunol.162.11.6658","article-title":"Perforin is a major contributor to NK cell control of tumor metastasis","volume":"162","author":"Smyth","year":"1999","journal-title":"J Immunol"},{"key":"key20180108114349_b33-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood.V97.1.192","article-title":"Perforin and interferon-gamma activities independently control tumor initiation, growth and metastasis","volume":"97","author":"Street","year":"2001","journal-title":"Blood"},{"key":"key20180108114349_b34-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat Immunol"},{"key":"key20180108114349_b35-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.ejca.2005.08.016","article-title":"The role of IL-6 and STAT3 in inflammation and cancer","volume":"41","author":"Hodge","year":"2005","journal-title":"Eur J Cancer"},{"key":"key20180108114349_b36-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/art.39295","article-title":"Inhibition of natural killer cell cytotoxicity by interleukin-6: Implications for the pathogenesis of macrophage activation syndrome","volume":"67","author":"Cifaldi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"key20180108114349_b37-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri802","article-title":"Development of anti-TNF therapy for rheumatoid arthritis","volume":"2","author":"Feldmann","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"key20180108114349_b38-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.10679","article-title":"Tumor necrosis factor antagonist therapy and lymphoma development: Twenty-six cases reported to the Food and Drug Administration","volume":"46","author":"Brown","year":"2002","journal-title":"Arthritis Rheum"},{"key":"key20180108114349_b39-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/art.27511","article-title":"Tumor necrosis factor alpha blockers and malignancy in children: Forty-eight cases reported to the Food and drug administration","volume":"62","author":"Diak","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key20180108114349_b40-ol-0-0-6473","first-page":"560","article-title":"Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis","volume":"118","author":"Popivanova","year":"2008","journal-title":"J Clin Invest"},{"key":"key20180108114349_b41-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1002\/ijc.21734","article-title":"TAK1-mediated stress signaling pathways are essential for TNF-alpha-promoted pulmonary metastasis of murine colon cancer cells","volume":"118","author":"Choo","year":"2006","journal-title":"Int J Cancer"},{"key":"key20180108114349_b42-ol-0-0-6473","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1158\/0008-5472.CAN-07-5301","article-title":"Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2","volume":"68","author":"Fichtner-Feigl","year":"2008","journal-title":"Cancer Res"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T04:14:38Z","timestamp":1692850478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.6473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,23]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,6,23]]},"published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.3892\/ol.2017.6473"],"URL":"https:\/\/doi.org\/10.3892\/ol.2017.6473","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,23]]}}}